The study’s primary objective is to evaluate the safety of Lomecel-B™ in Japan’s elderly population First-in-human clinical trial of Lomecel-B™ in Japan . | April 19, 2023
30.11.2021 - New trial is in collaboration with Japan’s National Center for Geriatrics and Gerontology (NCGG) and Juntendo University HospitalMIAMI, Nov. 30, 2021 (GLOBE NEWSWIRE) - Longeveron Inc. (NASDAQ: LGVN) ( Longeveron or the Company ), a clinical . Seite 1
E-Mail
The impact of the COVID-19 pandemic on public health is staggering; more than one hundred million cases and two million deaths worldwide. In response, most countries and local governments have taken substantial measures such as travel restrictions and physical distancing to keep their citizens safe. Both the pandemic and related protective measures pose challenges for ongoing clinical research studies seeking to treat and prevent the world s greatest public health emergencies including COVID-19, but also Alzheimer s disease and other dementia.
In a new paper from the World-Wide FINGERS network in Alzheimer s & Dementia: Translational Research and Clinical Interventions, first author Susanne Röhr, Ph.D., clinical psychologist at the Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Germany, and colleagues provide timely guidance on the design and management of clinical research during COVID-19 specifically on the conduct of